CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 16 filers reported holding CLEVELAND BIOLABS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 150 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 150 | -76.9% | 0.00% | – |
| Q3 2019 | $0 | – | 650 | +333.3% | 0.00% | – |
| Q4 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 150 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 150 | -76.9% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 650 | -16.1% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 775 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 775 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 775 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 775 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -33.3% | 775 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 281,916 | $567,000 | 0.00% |
| VANGUARD GROUP INC | 170,347 | $342,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 20 | $0 | 0.00% |
| UBS Group AG | 2,056 | $4,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 100 | $0 | 0.00% |
| IFP Advisors, Inc | 150 | $0 | 0.00% |
| Advisor Group, Inc. | 25 | $0 | 0.00% |
| US BANCORP \DE\ | 100 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 253 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |